Coda Reed, Waller Stephen, Vopat Bryan
From the The University of Kansas Medical Center, Kansas City, Kansas.
J Am Acad Orthop Surg Glob Res Rev. 2025 Apr 29;9(5). doi: 10.5435/JAAOSGlobal-D-24-00274. eCollection 2025 May 1.
Nontuberculosis Mycobacterium infections are rare but devastating infections in orthopaedic surgery. The complexity of treatment and the high rate of treatment failure for nontuberculosis Mycobacterium infections illustrate their unique pathogenesis and success at evading normal immune responses. To date, there is no formal treatment algorithm developed for managing these infections in orthopaedic surgery. Successful eradication relies on prolonged culture-specific antibiotic therapies coupled with surgical resection, implant/prosthesis removal, and occasionally amputations. These multidrug therapies often have a high rate of complications, drug-drug interactions, and poor tolerance, further increasing the complexity of treatment. Outlining the epidemiology, pathogenesis, diagnosis, and treatment guidelines of these rare but detrimental infections is essential to improving treatment success.
非结核分枝杆菌感染在骨科手术中较为罕见,但具有毁灭性。非结核分枝杆菌感染的治疗复杂性和高治疗失败率表明了其独特的发病机制以及逃避正常免疫反应的能力。迄今为止,尚未制定出用于骨科手术中管理这些感染的正式治疗方案。成功根除依赖于长期的针对性抗生素治疗,同时结合手术切除、取出植入物/假体,有时还需要截肢。这些多药治疗通常并发症发生率高、存在药物相互作用且耐受性差,进一步增加了治疗的复杂性。概述这些罕见但有害感染的流行病学、发病机制、诊断和治疗指南对于提高治疗成功率至关重要。